GlassScriptPhysician profile
Guy R Orangio
NPI 1740248046
$4,448.91
in general payments reported to CMS, 2019-2025
11 companies · $58.07 in 2025
The $58.07 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,767 · 2020: $723 · 2021: $210 · 2022: $290 · 2023: $353 · 2024: $47.63 · 2025: $58.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asensus Surgical, INC. | $1,589.37 | 2019-2020 | |
| Applied Medical Resources Corporation | $1,278.13 | 2019 | |
| Stryker Corporation | $365.88 | 2019-2023 | Spy-Phi System |
| Abbvie INC. | $315.69 | 2023-2025 | |
| Baxter Healthcare | $304.26 | 2019-2021 | |
| Intuitive Surgical, INC. | $286.41 | 2019-2022 | |
| Allergan, INC. | $210.70 | 2021-2022 | |
| Kerecis Limited | $56.93 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Takeda Pharmaceuticals U.S.A., INC. | $17.80 | 2019 | |
| Kci USA, INC. | $12.11 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Orangio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.